Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies.

Mofors J, Björk A, Smedby KE, Kvarnström M, Forsblad-d'Elia H, Magnusson-Bucher S, Eriksson P, Mandl T, Baecklund E, Nordmark G, Wahren-Herlenius M.

Ann Rheum Dis. 2019 Nov 6. pii: annrheumdis-2019-216287. doi: 10.1136/annrheumdis-2019-216287. [Epub ahead of print] No abstract available.

PMID:
31694814
2.

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis.

Hellbacher E, Hjorton K, Backlin C, Enblad G, Sundström C, Baecklund E, Knight A.

Acta Oncol. 2019 Nov;58(11):1655-1659. doi: 10.1080/0284186X.2019.1634833. Epub 2019 Aug 13. No abstract available.

PMID:
31407922
3.

Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival.

Tessier-Cloutier B, Twa DD, Baecklund E, Gascoyne R, Johnson NA, Backlin C, Kamen DL, Clarke AE, Ramsey-Goldman R, Lee JL, Farinha P, Bernatsky S.

Lupus Sci Med. 2019 May 4;6(1):e000324. doi: 10.1136/lupus-2019-000324. eCollection 2019.

4.

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome.

Mörth C, Valachis A, Abu Sabaa A, Marshall K, Hedström G, Flogegård M, Baecklund E, Enblad G.

Acta Oncol. 2019 Aug;58(8):1170-1177. doi: 10.1080/0284186X.2019.1619936. Epub 2019 May 25.

PMID:
31131659
5.

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.

Karlsson Sundbaum J, Eriksson N, Hallberg P, Lehto N, Wadelius M, Baecklund E.

Int J Rheum Dis. 2019 Jul;22(7):1226-1232. doi: 10.1111/1756-185X.13576. Epub 2019 Apr 22.

6.

Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjögren's syndrome.

Vasaitis L, Nordmark G, Theander E, Backlin C, Smedby KE, Askling J, Rönnblom L, Sundström C, Baecklund E.

Scand J Rheumatol. 2019 May;48(3):207-212. doi: 10.1080/03009742.2018.1523456. Epub 2018 Nov 13.

PMID:
30422723
7.

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation.

Kinch A, Sundström C, Baecklund E, Backlin C, Molin D, Enblad G.

Leuk Lymphoma. 2019 Feb;60(2):376-384. doi: 10.1080/10428194.2018.1480767. Epub 2018 Jul 22.

PMID:
30033844
8.

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.

Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, Askling J, Hochberg FH, Klareskog L, Kay J, Smedby KE.

Scand J Rheumatol. 2018 Jul;47(4):270-275. doi: 10.1080/03009742.2017.1376108. Epub 2018 Jan 16.

PMID:
29336646
9.

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.

Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d'Elia H, Askling J; ARTIS Study group.

Ann Rheum Dis. 2018 May;77(5):650-657. doi: 10.1136/annrheumdis-2017-212395. Epub 2017 Dec 13.

10.

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, Gottenberg JE, Morel J, Zavada J, Iannone F, Askling J, Listing J.

Ann Rheum Dis. 2017 Dec;76(12):2025-2030. doi: 10.1136/annrheumdis-2017-211623. Epub 2017 Aug 19.

11.

Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.

Ramírez Sepúlveda JI, Kvarnström M, Eriksson P, Mandl T, Norheim KB, Johnsen SJ, Hammenfors D, Jonsson MV, Skarstein K, Brun JG; DISSECT consortium, Rönnblom L, Forsblad-d'Elia H, Magnusson Bucher S, Baecklund E, Theander E, Omdal R, Jonsson R, Nordmark G, Wahren-Herlenius M.

Biol Sex Differ. 2017 Aug 8;8(1):25. doi: 10.1186/s13293-017-0146-6.

12.

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.

Enblad G, Martinsson G, Baecklund E, Hesselager G, Sundström C, Amini RM, Hagberg H.

Acta Oncol. 2017 Apr;56(4):599-607. doi: 10.1080/0284186X.2016.1270465. Epub 2017 Jan 13.

PMID:
28084866
13.

Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?

Hellgren K, Baecklund E, Backlin C, Sundstrom C, Smedby KE, Askling J.

Arthritis Rheumatol. 2017 Apr;69(4):700-708. doi: 10.1002/art.40017.

14.

Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis.

Vasaitis L, Sundström C, Backlin C, Nordmark G, Baecklund E.

Acta Oncol. 2016 Sep - Oct;55(9-10):1139-1144. doi: 10.1080/0284186X.2016.1182644. Epub 2016 May 19.

PMID:
27196149
15.

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease.

Brauner S, Zhou W, Backlin C, Green TM, Folkersen L, Ivanchenko M, Löfström B, Xu-Monette ZY, Young KH, Møller Pedersen L, Boe Møller M, Sundström C, Enblad G, Baecklund E, Wahren-Herlenius M.

J Intern Med. 2015 Sep;278(3):323-32. doi: 10.1111/joim.12375. Epub 2015 May 29.

16.

Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome.

Knight A, Hjorton K, Sundström C, Höglund M, Backlin C, Smedby KE, Askling J, Baecklund E.

J Rheumatol. 2015 Apr;42(4):690-4. doi: 10.3899/jrheum.141104. Epub 2015 Feb 1.

PMID:
25641890
17.

Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.

Kinch A, Cavelier L, Bengtsson M, Baecklund E, Enblad G, Backlin C, Thunberg U, Sundström C, Pauksens K.

Am J Transplant. 2014 Dec;14(12):2838-45. doi: 10.1111/ajt.12990. Epub 2014 Oct 10.

18.

Expression of intratumoral forkhead box protein 3 in posttransplant lymphoproliferative disorders: clinical features and survival outcomes.

Berglund D, Kinch A, Edman E, Backlin C, Enblad G, Larsson E, Molin D, Pauksens K, Sundström C, Baecklund E.

Transplantation. 2015 May;99(5):1036-42. doi: 10.1097/TP.0000000000000415.

PMID:
25211518
19.

Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.

Hellgren K, Smedby KE, Backlin C, Sundstrom C, Feltelius N, Eriksson JK, Baecklund E, Askling J.

Arthritis Rheumatol. 2014 May;66(5):1282-90. doi: 10.1002/art.38339.

20.

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Arkema EV, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, Askling J; ARTIS Study Group.

Ann Rheum Dis. 2015 Jun;74(6):1212-7. doi: 10.1136/annrheumdis-2013-204960. Epub 2014 Mar 7.

PMID:
24608401
21.

Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?

Baecklund E, Smedby KE, Sutton LA, Askling J, Rosenquist R.

Semin Cancer Biol. 2014 Feb;24:61-70. doi: 10.1016/j.semcancer.2013.12.001. Epub 2013 Dec 10. Review.

PMID:
24333759
22.

A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.

Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.

Acta Oncol. 2014 May;53(5):669-79. doi: 10.3109/0284186X.2013.844853. Epub 2013 Oct 28.

PMID:
24164103
23.
24.

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.

Simard JF, Baecklund F, Chang ET, Baecklund E, Hjalgrim H, -Olov Adami H, Glimelius B, Smedby KE.

Int J Cancer. 2013 Jun 1;132(11):2659-66. doi: 10.1002/ijc.27944. Epub 2012 Dec 3.

25.

Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.

Krynitz B, Edgren G, Lindelöf B, Baecklund E, Brattström C, Wilczek H, Smedby KE.

Int J Cancer. 2013 Mar 15;132(6):1429-38. doi: 10.1002/ijc.27765. Epub 2012 Aug 28.

26.

Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients.

Fernberg P, Edgren G, Adami J, Ingvar A, Bellocco R, Tufveson G, Höglund P, Kinch A, Simard JF, Baecklund E, Lindelöf B, Pawitan Y, Smedby KE.

Am J Transplant. 2011 Nov;11(11):2472-82. doi: 10.1111/j.1600-6143.2011.03704.x. Epub 2011 Aug 22.

27.

Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.

Löfström B, Backlin C, Pettersson T, Lundberg IE, Baecklund E.

J Rheumatol. 2011 Sep;38(9):1891-7. doi: 10.3899/jrheum.101190. Epub 2011 Jul 1.

PMID:
21724695
28.

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.

Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, Brokstad K, Jonsson R, Jonsson MV.

Ann Rheum Dis. 2011 Aug;70(8):1363-8. doi: 10.1136/ard.2010.144782.

29.

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma.

Baecklund E, Backlin C, Mansouri M, Klareskog L, Askling J, Iliadou AN, Enblad G, Lossos IS, Natkunam Y, Rosenquist R.

Leuk Lymphoma. 2011 Jun;52(6):1146-9. doi: 10.3109/10428194.2011.559801. Epub 2011 Feb 28. No abstract available.

PMID:
21375434
30.

Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden.

Simard JF, Baecklund E, Kinch A, Brattström C, Ingvar A, Molin D, Adami J, Fernberg P, Wilczek H, Ekbom A, Smedby KE.

Am J Transplant. 2011 Jan;11(1):146-51. doi: 10.1111/j.1600-6143.2010.03367.x.

31.

Ten years with biologics: to whom do data on effectiveness and safety apply?

Simard JF, Arkema EV, Sundström A, Geborek P, Saxne T, Baecklund E, Coster L, Dackhammar C, Jacobsson L, Feltelius N, Lindblad S, Rantapää-Dahlqvist S, Klareskog L, van Vollenhoven RF, Neovius M, Askling J.

Rheumatology (Oxford). 2011 Jan;50(1):204-13. doi: 10.1093/rheumatology/keq326. Epub 2010 Nov 16.

PMID:
21084326
32.

Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.

Nordmark G, Kristjansdottir G, Theander E, Appel S, Eriksson P, Vasaitis L, Kvarnström M, Delaleu N, Lundmark P, Lundmark A, Sjöwall C, Brun JG, Jonsson MV, Harboe E, Gøransson LG, Johnsen SJ, Söderkvist P, Eloranta ML, Alm G, Baecklund E, Wahren-Herlenius M, Omdal R, Rönnblom L, Jonsson R, Syvänen AC.

Genes Immun. 2011 Mar;12(2):100-9. doi: 10.1038/gene.2010.44. Epub 2010 Sep 23.

PMID:
20861858
33.

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study.

Sokka T, Kautiainen H, Pincus T, Verstappen SM, Aggarwal A, Alten R, Andersone D, Badsha H, Baecklund E, Belmonte M, Craig-Müller J, da Mota LM, Dimic A, Fathi NA, Ferraccioli G, Fukuda W, Géher P, Gogus F, Hajjaj-Hassouni N, Hamoud H, Haugeberg G, Henrohn D, Horslev-Petersen K, Ionescu R, Karateew D, Kuuse R, Laurindo IM, Lazovskis J, Luukkainen R, Mofti A, Murphy E, Nakajima A, Oyoo O, Pandya SC, Pohl C, Predeteanu D, Rexhepi M, Rexhepi S, Sharma B, Shono E, Sibilia J, Sierakowski S, Skopouli FN, Stropuviene S, Toloza S, Valter I, Woolf A, Yamanaka H; QUEST-RA.

Arthritis Res Ther. 2010;12(2):R42. doi: 10.1186/ar2951. Epub 2010 Mar 12.

34.

Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.

Hellgren K, Smedby KE, Feltelius N, Baecklund E, Askling J.

Arthritis Rheum. 2010 May;62(5):1252-8. doi: 10.1002/art.27402.

35.

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?

Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, Dackhammar C, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Arthritis Rheum. 2009 Nov;60(11):3180-9. doi: 10.1002/art.24941.

36.

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.

Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, Hetland ML, Peets T, Immonen K, Maillefert JF, Drosos AA, Alten R, Pohl C, Rojkovich B, Bresnihan B, Minnock P, Cazzato M, Bombardieri S, Rexhepi S, Rexhepi M, Andersone D, Stropuviene S, Huisman M, Sierakowski S, Karateev D, Skakic V, Naranjo A, Baecklund E, Henrohn D, Gogus F, Badsha H, Mofti A, Taylor P, McClinton C, Yazici Y.

Ann Rheum Dis. 2009 Nov;68(11):1666-72. doi: 10.1136/ard.2009.109983. Epub 2009 Jul 30.

37.

Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study.

Hellgren K, Iliadou A, Rosenquist R, Feltelius N, Backlin C, Enblad G, Askling J, Baecklund E.

Ann Rheum Dis. 2010 Apr;69(4):654-9. doi: 10.1136/ard.2008.096925. Epub 2009 May 12.

PMID:
19439429
38.

Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.

Smedby KE, Askling J, Mariette X, Baecklund E.

J Intern Med. 2008 Dec;264(6):514-27. doi: 10.1111/j.1365-2796.2008.02029.x. Review.

39.

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.

Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, Bertilsson L, Cöster L, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven R, Klareskog L, Feltelius N.

Ann Rheum Dis. 2009 May;68(5):648-53. doi: 10.1136/ard.2007.085852. Epub 2008 May 8.

PMID:
18467516
40.

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis.

Baecklund E, Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, Feltelius N, Klareskog L, Enblad G, Lossos IS, Levy R, Sundström C, Rosenquist R.

Br J Haematol. 2008 Apr;141(1):69-72. doi: 10.1111/j.1365-2141.2008.07011.x.

PMID:
18324968
41.

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.

Sokka T, Kautiainen H, Toloza S, Mäkinen H, Verstappen SM, Lund Hetland M, Naranjo A, Baecklund E, Herborn G, Rau R, Cazzato M, Gossec L, Skakic V, Gogus F, Sierakowski S, Bresnihan B, Taylor P, McClinton C, Pincus T; QUEST-RA Group.

Ann Rheum Dis. 2007 Nov;66(11):1491-6. Epub 2007 Apr 5.

42.

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, van Vollenhoven RF, Klareskog L.

Ann Rheum Dis. 2007 Oct;66(10):1339-44. Epub 2007 Jan 29. Erratum in: Ann Rheum Dis. 2007 Nov;66(11):1548.

43.

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.

Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini RM, Feltelius N, Enblad G, Sundström C, Klareskog L, Askling J, Rosenquist R.

Arthritis Rheum. 2006 Dec;54(12):3774-81.

44.

Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics.

Smedby KE, Baecklund E, Askling J.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2069-77. Review.

45.

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis.

Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundström C, Klareskog L.

Arthritis Rheum. 2006 Mar;54(3):692-701.

46.

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N.

Arthritis Rheum. 2005 Jul;52(7):1986-92.

47.

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N.

Ann Rheum Dis. 2005 Oct;64(10):1414-20. Epub 2005 Apr 20.

48.

Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.

Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.

Ann Rheum Dis. 2005 Dec;64(12):1765-8. Epub 2005 Apr 20.

49.

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists.

Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L.

Ann Rheum Dis. 2005 Oct;64(10):1421-6. Epub 2005 Apr 13.

50.

Rheumatoid arthritis and malignant lymphomas.

Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L.

Curr Opin Rheumatol. 2004 May;16(3):254-61. Review.

PMID:
15103253

Supplemental Content

Loading ...
Support Center